Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.

NCT01675882 is registered in ClinicalTrials.gov with DBV Technologies as lead sponsor.

NCT NCT01675882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01675882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Lead sponsor
DBV Technologies
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2012
Completion date
July 31, 2014
Enrollment
221 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

peanut allergy